Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
주사 약물전달 시장 - 조사 범위
TMR의 조사 보고서 "세계 주사 약물전달 시장"은 2024-2034년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측 연도로 하여 2018-2034년까지의 세계 주사 약물전달 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 주사 약물전달 시장의 연평균 성장률(CAGR %)도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서 분석가들은 주요 오피니언 리더, 업계 리더 및 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료 등을 참고하여 주사 약물전달 시장을 추론했습니다.
| 시장 스냅샷 |
| 2023년 시장 규모 |
6,895억 달러 |
| 2034년 시장 규모 |
1조 9,000억 달러 |
| CAGR |
9.8% |
이 보고서는 세계 주사 약물전달 시장의 경쟁 환경을 조사하고 있습니다. 세계 주사 약물전달 시장에서 활동하는 주요 업체를 파악하고, 각 업체는 다양한 속성별로 프로파일을 작성했습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등이 이 보고서에서 소개하는 세계 주사 약물전달 시장 참여자의 속성입니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
- 소개
- 개요
- 시장 역학
- 세계의 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
- PEST 분석
- 제품 발매와 승인
- 주요 지역/국가의 규제 상황
- FDA 의약품 승인 프로세스
- 주요 업계 이벤트(인수, 파트너십, 협업)
제6장 세계의 시장 분석과 예측 : 제품 유형별
- 소개와 정의
- 주요 조사 결과/ 진전
- 시장 금액 예측 : 제품 유형별, 2020-2034년
- 기기
- 처방
- 기존 약물전달 제제
- 새로운 약물전달 제제
- 지속성 있는 주사제
- 제품 유형별 시장 매력
제7장 세계의 시장 분석과 예측 : 치료 용도별
- 소개와 정의
- 주요 조사 결과/ 진전
- 시장 금액 예측 : 치료 용도별, 2020-2034년
- 자가면역질환
- 호르몬질환
- 희귀질환
- 암
- 심혈관질환
- 감염증
- 기타
- 치료 용도별 시장 매력
제8장 세계의 시장 분석과 예측 : 이용 패턴별
- 소개와 정의
- 주요 조사 결과/ 진전
- 시장 금액 예측 : 이용 패턴별, 2020-2034년
- 이용 패턴별 시장 매력
제9장 세계의 시장 분석과 예측 : 최종사용자별
- 소개와 정의
- 주요 조사 결과/ 진전
- 시장 금액 예측 : 최종사용자별, 2020-2034년
- 최종사용자별 시장 매력
제10장 세계의 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 국가·지역별 시장 매력
제11장 북미의 시장 분석과 예측
제12장 유럽의 시장 분석과 예측
제13장 아시아태평양의 시장 분석과 예측
- 중국
- 인도
- 일본
- 호주와 뉴질랜드
- 기타 아시아태평양
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카의 시장 분석과 예측
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
제16장 경쟁 상황
- 시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
- 시장 점유율 분석 기업별(2021년)
- 시장 발자국 분석
- 경쟁적 비즈니스 전략
- 기업 개요
- 시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
- 시장 점유율 분석 : 기업별(2023년)
- 기업 개요
ksm
Injectable Drug Delivery Market - Scope of Report
TMR's report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.
| Market Snapshot |
|---|
| Market Value in 2023 | US$ 689.5 Bn |
| Market Value in 2034 | US$ 1.9 Trn |
| CAGR | 9.8% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.
The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.
Key Questions Answered in Global injectable drug delivery Market Report:
- What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
- What are the opportunities in the global injectable drug delivery market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Injectable Drug Delivery Market - Research Objectives and Research Approach
The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Injectable Drug Delivery Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. PEST Analysis
- 5.2. Product Launches and Approvals
- 5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
- 5.4. FDA Drug Approval Process
- 5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)
6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Product Type, 2020-2034
- 6.3.1. Devices
- 6.3.1.1. Conventional Injection Devices
- 6.3.1.2. Self Injection Devices
- 6.3.1.3. Others
- 6.3.2. Formulations
- 6.3.2.1. Conventional Drug Delivery Formulations
- 6.3.2.2. Novel Drug Delivery Formulations
- 6.3.2.3. Long Lasting Injection Formulations
- 6.4. Market Attractiveness By Product Type
7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 7.3.1. Autoimmune Disease
- 7.3.2. Hormone Disease
- 7.3.3. Orphan Disease
- 7.3.4. Cancer
- 7.3.5. Cardiovascular Disease
- 7.3.6. Infectious Disease
- 7.3.7. Others
- 7.4. Market Attractiveness By Therapeutic Application
8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By Usage Pattern, 2020-2034
- 8.3.1. Curative Care
- 8.3.2. Immunization
- 8.3.3. Others
- 8.4. Market Attractiveness By Usage Pattern
9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Hospitals and Clinics
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Home Care Settings
- 9.3.4. Others
- 9.4. Market Attractiveness By End-user
10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region
- 10.1. Key Findings
- 10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness By Country/Region
11. North America Injectable Drug Delivery Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast By Product Type, 2020-2034
- 11.2.1. Devices
- 11.2.1.1. Conventional Injection Devices
- 11.2.1.2. Self Injection Devices
- 11.2.1.3. Others
- 11.2.2. Formulations
- 11.2.2.1. Conventional Drug Delivery Formulations
- 11.2.2.2. Novel Drug Delivery Formulations
- 11.2.2.3. Long Lasting Injection Formulations
- 11.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 11.3.1. Autoimmune Disease
- 11.3.2. Hormone Disease
- 11.3.3. Orphan Disease
- 11.3.4. Cancer
- 11.3.5. Cardiovascular Disease
- 11.3.6. Infectious Disease
- 11.3.7. Others
- 11.4. Market Value Forecast By Usage Pattern, 2020-2034
- 11.4.1. Curative Care
- 11.4.2. Immunization
- 11.4.3. Others
- 11.5. Market Value Forecast By End-user, 2020-2034
- 11.5.1. Hospitals and Clinics
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Home Care Settings
- 11.5.4. Others
- 11.6. Market Value Forecast By Country, 2020-2034
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product Type
- 11.7.2. By Therapeutic Application
- 11.7.3. By Usage Pattern
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Injectable Drug Delivery Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast By Product Type, 2020-2034
- 12.2.1. Devices
- 12.2.1.1. Conventional Injection Devices
- 12.2.1.2. Self Injection Devices
- 12.2.1.3. Others
- 12.2.2. Formulations
- 12.2.2.1. Conventional Drug Delivery Formulations
- 12.2.2.2. Novel Drug Delivery Formulations
- 12.2.2.3. Long Lasting Injection Formulations
- 12.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 12.3.1. Autoimmune Disease
- 12.3.2. Hormone Disease
- 12.3.3. Orphan Disease
- 12.3.4. Cancer
- 12.3.5. Cardiovascular Disease
- 12.3.6. Infectious Disease
- 12.3.7. Others
- 12.4. Market Value Forecast By Usage Pattern, 2020-2034
- 12.4.1. Curative Care
- 12.4.2. Immunization
- 12.4.3. Others
- 12.5. Market Value Forecast By End-user, 2020-2034
- 12.5.1. Hospitals and Clinics
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Home Care Settings
- 12.5.4. Others
- 12.6. Market Value Forecast By Country, 2020-2034
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product Type
- 12.7.2. By Therapeutic Application
- 12.7.3. By Usage Pattern
- 12.7.4. By End-user
- 12.7.5. By Country
13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast By Product Type, 2020-2034
- 13.2.1. Devices
- 13.2.1.1. Conventional Injection Devices
- 13.2.1.2. Self Injection Devices
- 13.2.1.3. Others
- 13.2.2. Formulations
- 13.2.2.1. Conventional Drug Delivery Formulations
- 13.2.2.2. Novel Drug Delivery Formulations
- 13.2.2.3. Long Lasting Injection Formulations
- 13.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 13.3.1. Autoimmune Disease
- 13.3.2. Hormone Disease
- 13.3.3. Orphan Disease
- 13.3.4. Cancer
- 13.3.5. Cardiovascular Disease
- 13.3.6. Infectious Disease
- 13.3.7. Others
- 13.4. Market Value Forecast By Usage Pattern, 2020-2034
- 13.4.1. Curative Care
- 13.4.2. Immunization
- 13.4.3. Others
- 13.5. Market Value Forecast By End-user, 2020-2034
- 13.5.1. Hospitals and Clinics
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Home Care Settings
- 13.5.4. Others
- 13.6. Market Value Forecast By Country, 2020-2034
- 13.6.1. China
- 13.6.2. India
- 13.6.3. Japan
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product Type
- 13.7.2. By Therapeutic Application
- 13.7.3. By Usage Pattern
- 13.7.4. By End-user
- 13.7.5. By Country
14. Latin America Injectable Drug Delivery Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast By Product Type, 2020-2034
- 14.2.1. Devices
- 14.2.1.1. Conventional Injection Devices
- 14.2.1.2. Self Injection Devices
- 14.2.1.3. Others
- 14.2.2. Formulations
- 14.2.2.1. Conventional Drug Delivery Formulations
- 14.2.2.2. Novel Drug Delivery Formulations
- 14.2.2.3. Long Lasting Injection Formulations
- 14.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 14.3.1. Autoimmune Disease
- 14.3.2. Hormone Disease
- 14.3.3. Orphan Disease
- 14.3.4. Cancer
- 14.3.5. Cardiovascular Disease
- 14.3.6. Infectious Disease
- 14.3.7. Others
- 14.4. Market Value Forecast By Usage Pattern, 2020-2034
- 14.4.1. Curative Care
- 14.4.2. Immunization
- 14.4.3. Others
- 14.5. Market Value Forecast By End-user, 2020-2034
- 14.5.1. Hospitals and Clinics
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Home Care Settings
- 14.5.4. Others
- 14.6. Market Value Forecast By Country, 2020-2034
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product Type
- 14.7.2. By Therapeutic Application
- 14.7.3. By Usage Pattern
- 14.7.4. By End-user
- 14.7.5. By Country
15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast By Product Type, 2020-2034
- 15.2.1. Devices
- 15.2.1.1. Conventional Injection Devices
- 15.2.1.2. Self Injection Devices
- 15.2.1.3. Others
- 15.2.2. Formulations
- 15.2.2.1. Conventional Drug Delivery Formulations
- 15.2.2.2. Novel Drug Delivery Formulations
- 15.2.2.3. Long Lasting Injection Formulations
- 15.3. Market Value Forecast By Therapeutic Application, 2020-2034
- 15.3.1. Autoimmune Disease
- 15.3.2. Hormone Disease
- 15.3.3. Orphan Disease
- 15.3.4. Cancer
- 15.3.5. Cardiovascular Disease
- 15.3.6. Infectious Disease
- 15.3.7. Others
- 15.4. Market Value Forecast By Usage Pattern, 2020-2034
- 15.4.1. Curative Care
- 15.4.2. Immunization
- 15.4.3. Others
- 15.5. Market Value Forecast By End-user, 2020-2034
- 15.5.1. Hospitals and Clinics
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Home Care Settings
- 15.5.4. Others
- 15.6. Market Value Forecast By Country, 2020-2034
- 15.6.1. GCC
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product Type
- 15.7.2. By Therapeutic Application
- 15.7.3. By Usage Pattern
- 15.7.4. By End-user
- 15.7.5. By Country
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 16.2. Market Share Analysis By Company (2021)
- 16.3. Market Footprint Analysis
- 16.3.1. By Region
- 16.3.2. By Product Type
- 16.4. Competitive Business Strategies
- 16.5. Company Profiles
- 16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 16.5.2. Market Share Analysis, by Company (2023)
- 16.5.3. Company Profiles
- 16.5.3.1. Becton, Dickinson, and Company (BD)
- 16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.1.2. Product Portfolio
- 16.5.3.1.3. Financial Overview
- 16.5.3.1.4. SWOT Analysis
- 16.5.3.1.5. Strategic Overview
- 16.5.3.2. Pfizer, Inc.
- 16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.2.2. Product Portfolio
- 16.5.3.2.3. Financial Overview
- 16.5.3.2.4. SWOT Analysis
- 16.5.3.2.5. Strategic Overview
- 16.5.3.3. Eli Lilly and Company
- 16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.3.2. Product Portfolio
- 16.5.3.3.3. Financial Overview
- 16.5.3.3.4. SWOT Analysis
- 16.5.3.3.5. Strategic Overview
- 16.5.3.4. Baxter International, Inc.
- 16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.4.2. Product Portfolio
- 16.5.3.4.3. Financial Overview
- 16.5.3.4.4. SWOT Analysis
- 16.5.3.4.5. Strategic Overview
- 16.5.3.5. Terumo Corporation
- 16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.5.2. Product Portfolio
- 16.5.3.5.3. Financial Overview
- 16.5.3.5.4. SWOT Analysis
- 16.5.3.5.5. Strategic Overview
- 16.5.3.6. B. Braun Melsungen AG
- 16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.6.2. Product Portfolio
- 16.5.3.6.3. Financial Overview
- 16.5.3.6.4. SWOT Analysis
- 16.5.3.6.5. Strategic Overview
- 16.5.3.7. Ypsomed AG
- 16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.7.2. Product Portfolio
- 16.5.3.7.3. Financial Overview
- 16.5.3.7.4. SWOT Analysis
- 16.5.3.7.5. Strategic Overview
- 16.5.3.8. Gerresheimer AG
- 16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.8.2. Product Portfolio
- 16.5.3.8.3. Financial Overview
- 16.5.3.8.4. SWOT Analysis
- 16.5.3.8.5. Strategic Overview
- 16.5.3.9. SCHOTT Pharma
- 16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.9.2. Product Portfolio
- 16.5.3.9.3. Financial Overview
- 16.5.3.9.4. SWOT Analysis
- 16.5.3.9.5. Strategic Overview
- 16.5.3.10. Hi-Tech Syringes
- 16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.5.3.10.2. Product Portfolio
- 16.5.3.10.3. Financial Overview
- 16.5.3.10.4. SWOT Analysis
- 16.5.3.10.5. Strategic Overview
